ApaTech is a world leader in synthetic bone graft technologies. Our mission is to provide surgeons with superior, proprietary, bone graft solutions, helping them improve clinical outcomes and patient quality of life. ApaTech was formed in 2001 with the rights to bone materials research and IP from London and Cambridge Universities. The company retains pipeline agreements with founding inventors, including Professor William Bonfield, CBE and Queen Mary University of London. CE Mark and 510K clearance for its first bone graft substitute ApaPore and for Actifuse, a new class of bone graft material that combines osteoconductive and osteo-stimulatory activities, in a wide range of orthopaedic and spinal applications. Actifuse is being used in Europe, the United States and Australasia for spinal fusions, bone tumor void filling, fractures and including use in the spine.* The HQ and manufacturing facility are based in Elstree (Northwest London) England, with the U.S. operations located in Foxborough, MA, in the greater Boston area.